David J. Wambeke, Chief Business Officer at DiaMedica Therapeutics Inc. (DMAC), bought 76,728 shares at $3.91 ($300K) on 2023-06-23, disclosed to the SEC on 2023-06-26.
Open-market purchase of $300k DMAC by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.91 | 38,364 | $150K | 50.0% |
| 2 | $3.91 | 38,364 | $150K | 50.0% |
| Total | $3.91 avg | 76,728 | $300K | 100% |
| Filing → |
| DMAC | BUY | 2023-11-16 | $49K | — | Filing → |
| DMAC | BUY | 2023-04-11 | $750K | — | Filing → |